HoldingsChannel.com
NRX Pharmaceuticals insider buying image
The table below summarizes the most recent NRX Pharmaceuticals insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why NRX Pharmaceuticals insider buys are important for investors to follow.
DateInsiderPriceAmount
8-30-2023
Insider Buy
Aaron Gorovitz
$0.32
CAGR »
$11,196.50
35,000 shares
8-30-2023
Insider Buy
Chaim Hurvitz
$0.29
CAGR »
$20,125.00
70,000 shares
8-23-2023
Insider Buy
Jonathan C. Javitt
Chief Scientist
$0.33
CAGR »
$33,000.00
100,000 shares
8-22-2023
Insider Buy
Jonathan C. Javitt
Chief Scientist
$0.32
CAGR »
$64,400.00
200,000 shares
11-25-2022
Insider Buy
Seth Van Voorhees
CHIEF FINANCIAL OFFICER
$1.11
CAGR »
$18,215.23
16,337 shares
12-16-2022
Insider Buy
Stephen H. Willard
CHIEF EXECUTIVE OFFICER
$1.17
CAGR »
$58,500.00
50,000 shares
11-28-2022
Insider Buy
Patrick John Flynn
$1.25
CAGR »
$14,662.50
11,750 shares
11-25-2022
Insider Buy
Seth Van Voorhees
CHIEF FINANCIAL OFFICER
$1.11
CAGR »
$18,215.23
16,337 shares
11-18-2022
Insider Buy
Chaim Hurvitz
Director
$1.03
CAGR »
$514,905.08
500,000 shares
6-1-2022
Insider Buy
Jonathan C. Javitt
Chief Scientist
$0.58
CAGR »
$58,000.00
100,000 shares

Also See: Institutional Holders of NRXP
Also See: SEC filings

NRXP Performance Since Insider Purchase
Below we present the annualized performance delivered by NRX Pharmaceuticals stock since 8-30-2023 (the date of the most recent insider purchase). The performance of the investment from the time NRX Pharmaceuticals insider buying occurred is the ultimate test of whether insiders were right about NRXP being a good buy.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 08/31/2023
End date: 04/26/2024
Start price/share: $2.95
End price/share: $3.54
Dividends collected/share: $0.00
Total return: 20.00%
Annualized Gain: 30.54%
Starting investment: $10,000.00
Ending investment: $12,000.00
Years: 0.65

NRX Pharmaceuticals Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent NRX Pharmaceuticals insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding NRXP

Quotes delayed 20 minutes

Email EnvelopeFree NRXP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Other companies seeing insider buying close in time to when the NRX Pharmaceuticals Insider Buying occurred are:

Douglas Dynamics Insider Buying
Lamar Advertising Co (New) Insider Buying
Catalent Insider Buying
DigitalOcean Holdings Insider Buying
Aclaris Therapeutics Insider Buying
Foot Locker Insider Buying
1-800 Flowers.com Insider Buying
Tidewater Inc (New) Insider Buying
Sealed Air Insider Buying
Akoya Biosciences Insider Buying

NRX Pharmaceuticals Insider Buying | www.HoldingsChannel.com

Copyright © 2013 - 2024, All Rights Reserved Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.